Cantor downgrades ADMA Biologics stock rating on short report concerns

try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Iran rejects U.S. war proposal, says no talks before conditions met Oil prices climb over 2% as Iran reviews US proposal to end war This is the hottest stock in the market because of its Claude exposure MU, WDC, SNDK fall: Why Google’s TurboQuant is rattling memory stocks (South Africa Philippines Nigeria) Cantor downgrades ADMA Biologics stock rating on short report concerns By Analyst Ratings Published 03/26/2026, 04:33 AM Cantor downgrades ADMA Biologics stock rating on short report concerns 0 ADMA -15.00% Investing.com - Cantor Fitzgerald downgraded ADMA Biologics (NASDAQ:ADMA) to Neutral from Overweight following pressure on the shares from a short report alleging the company is boosting ASCENIV revenues through channel stuffing. The stock plunged 35.9% over the past week to $9.63, contributing to a 47% decline year-to-date. The firm suspended its financial model for the company after speaking with management and several investors. Investors expressed disappointment in the company’s response on Tuesday and the lack of direct communication, which management attributed to being in a quiet period. While ADMA Biologics issued a statement, Cantor Fitzgerald said it expected more specific feedback addressing the direct claims in the short report. The firm said it would have increased its comfort if the company addressed all individual items with a stronger defense. The downgrade reflects concerns around increased days sales outstanding and accounts receivables. Cantor Fitzgerald said the lack of clarity makes it difficult to recommend investors take advantage of stock weakness. Despite the selloff, InvestingPro analysis suggests ADMA remains undervalued at current levels, with an InvestingPro Tip noting the RSI indicates oversold territory. For deeper insights, investors can access ADMA’s comprehensive Pro Research Report, available for this and 1,400+ other US equities. The firm said investors are looking for...